Clinical Centre Nis, Clinic for Oncology

Niš 18000

0 studies enrolling now · 3 studies all time

What they study most

HER2-Positive Early Breast Cancer, Triple Negative Breast Neoplasms, Urothelial Carcinoma

Studies at this site

• A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer — Completed
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer — Completed